STATE-OF-THE-ART PAPER
Biomaterials for the Treatment of Myocardial Infarction
Karen L. Christman, PhD* and
Randall J. Lee, MD, PhD*, , ,*
* University of California-Berkeley and San Francisco Joint Bioengineering Graduate Group, Berkeley and San Francisco, California
Department of Medicine, University of California-San Francisco, San Francisco, California.
Cardiovascular Research Institute, University of California-San Francisco, San Francisco, California.
Manuscript received December 19, 2005;
revised manuscript received April 24, 2006,
accepted May 2, 2006.
* Reprint requests and correspondence: Dr. Randall J. Lee, Cardiac Electrophysiology, MU East Tower, Box 1354, 500 Parnassus Avenue, San Francisco, California 94143-1354. (Email: lee{at}medicine.ucsf.edu).
For nearly a decade, researchers have investigated the possibility of cell transplantation for cardiac repair. More recently, the emerging fields of tissue engineering and biomaterials have begun to provide potential treatments. Tissue engineering approaches are designed to repair lost or damaged tissue through the use of growth factors, cellular transplantation, and biomaterial scaffolds. There are currently 3 biomaterial approaches for the treatment of myocardial infarction (MI). The first involves polymeric left ventricular restraints in the prevention of heart failure. The second utilizes in vitro engineered cardiac tissue, which is subsequently implanted in vivo. The final approach entails injecting cells and/or a scaffold into the myocardium to create in situ engineered cardiac tissue. This review gives an overview of the current progress in the growing field of biomaterials for the treatment of MI.
|
Abbreviations and Acronyms
| | CSD = cardiac support device | | LV = left ventricle | | MI = myocardial infarction | | MMP = matrix metalloprotease | | PNIPAAM = poly(N-isopropylacrylamide) |
|
This article has been cited by other articles:
|
|
|
|
 
J. K. Willmann, R. Paulmurugan, M. Rodriguez-Porcel, W. Stein, T. J. Brinton, A. J. Connolly, C. H. Nielsen, A. M. Lutz, J. Lyons, F. Ikeno, et al.
Imaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals
Radiology,
July 1, 2009;
252(1):
117 - 127.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Pilla, J. H. Gorman III, and R. C. Gorman
Theoretic impact of infarct compliance on left ventricular function.
Ann. Thorac. Surg.,
March 1, 2009;
87(3):
803 - 810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-C. Wang, C.-H. Chen, S.-M. Hwang, W.-W. Lin, C.-H. Huang, W.-Y. Lee, Y. Chang, and H.-W. Sung
Spherically Symmetric Mesenchymal Stromal Cell Bodies Inherent with Endogenous Extracellular Matrices for Cellular Cardiomyoplasty
Stem Cells,
March 1, 2009;
27(3):
724 - 732.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yu, K. L. Christman, E. Chin, R. E. Sievers, M. Saeed, and R. J. Lee
Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy.
J. Thorac. Cardiovasc. Surg.,
January 1, 2009;
137(1):
180 - 187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Wang, D.-Q. Wu, X.-J. Jiang, X.-Z. Zhang, X.-Y. Li, J.-F. Zhang, Z.-B. Zheng, R. Zhuo, H. Jiang, and C. Huang
Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling
Eur J Heart Fail,
January 1, 2009;
11(1):
14 - 19.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Madonna and R. De Caterina
In vitro neovasculogenic potential of resident adipose tissue precursors
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1271 - C1280.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Mukherjee, J. A. Zavadzkas, S. M. Saunders, J. E. McLean, L. B. Jeffords, C. Beck, R. E. Stroud, A. M. Leone, C. N. Koval, W. T. Rivers, et al.
Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs
Ann. Thorac. Surg.,
October 1, 2008;
86(4):
1268 - 1276.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-H. Chen, H.-J. Wei, W.-W. Lin, I. Chiu, S.-M. Hwang, C.-C. Wang, W.-Y. Lee, Y. Chang, and H.-W. Sung
Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair
Cardiovasc Res,
October 1, 2008;
80(1):
88 - 95.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ota, N. A. Patronik, D. Schwartzman, C. N. Riviere, and M. A. Zenati
Minimally Invasive Epicardial Injections Using a Novel Semiautonomous Robotic Device
Circulation,
September 30, 2008;
118(14_suppl_1):
S115 - S120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Jawad, A. R. Lyon, S. E. Harding, N. N. Ali, and A. R. Boccaccini
Myocardial tissue engineering
Br. Med. Bull.,
September 1, 2008;
87(1):
31 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Landa, L. Miller, M. S. Feinberg, R. Holbova, M. Shachar, I. Freeman, S. Cohen, and J. Leor
Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat
Circulation,
March 18, 2008;
117(11):
1388 - 1396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier
Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
901 - 908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
